European follow-up of incorrect biomarker results for colorectal cancer demonstrates the importance of quality improvement projects

Biomarker analysis for colorectal cancer has been shown to be reliable in Europe with 97% of samples tested by EQA participants to be correctly classified. This study focuses on errors during the annual EQA assessment. The aim was to explore the causes and actions related to the observed errors and...

Descripción completa

Detalles Bibliográficos
Autores principales: Keppens, Cleo, Dufraing, Kelly, van Krieken, Han J., Siebers, Albert G., Kafatos, George, Lowe, Kimberly, Demonty, Gaston, Dequeker, Elisabeth M. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611891/
https://www.ncbi.nlm.nih.gov/pubmed/30719547
http://dx.doi.org/10.1007/s00428-019-02525-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611891/
https://www.ncbi.nlm.nih.gov/pubmed/30719547
http://dx.doi.org/10.1007/s00428-019-02525-9

Ejemplares similares